Cargando…
Reimbursement of orphan drugs in Belgium: what (else) matters?
BACKGROUND: Most orphan drugs do not meet traditional standards of cost-effectiveness. Yet, most orphan drugs are reimbursed, which implies that other factors are taken into account at the time of reimbursement. To increase accountability of decision-makers, there is a need for more transparency in...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172832/ https://www.ncbi.nlm.nih.gov/pubmed/25208770 http://dx.doi.org/10.1186/s13023-014-0139-z |